Anavex Life Sciences (AVXL) Tax Provisions (2016 - 2025)
Anavex Life Sciences (AVXL) reported Tax Provisions of $18000.0 for Q4 2025, up 126.87% sequentially from -$67000.0 in Q2 2024.
Anavex Life Sciences (AVXL) Tax Provisions (2016 - 2025) Analysis & Trends
Anavex Life Sciences (AVXL) has 10 years of Tax Provisions data on file, last reported at $18000.0 in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions changed N/A year-over-year to $18000.0; the trailing twelve-month figure through Dec 2025 stood at $141000.0 (changed N/A YoY), and the FY2023 full-year result was $7000.0, down 98.04% from the prior year.
- Tax Provisions improved to $18000.0 in Q4 2025, from -$67000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $209799.0 in Q3 2022 to a low of -$67000.0 in Q2 2024.
- A 5-year average of $47647.9 and a median of $39000.0 in 2021 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions surged 1553.32% in 2021 and sank 263.41% in 2024, its largest moves.
- Tracing AVXL's Tax Provisions over 5 years: stood at $29980.0 in 2021, then sank by 166.71% to -$20000.0 in 2022, then jumped by 525.0% to $85000.0 in 2023, then slumped by 178.82% to -$67000.0 in 2024, then soared by 126.87% to $18000.0 in 2025.
- Business Quant data shows AVXL's Tax Provisions at $18000.0 in Q4 2025, -$67000.0 in Q2 2024, and $105000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Anavex Life Sciences | 214.12 Mn | 82.37 Mn | - | 18,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,000.00 |
| Jun 30, 2024 | -67,000.00 |
| Mar 31, 2024 | 105,000.00 |
| Dec 31, 2023 | 85,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | -20,000.00 |
| Sep 30, 2022 | 209,799.00 |
| Jun 30, 2022 | 88,421.00 |
| Mar 31, 2022 | 29,800.00 |
| Dec 31, 2021 | 29,980.00 |
| Sep 30, 2021 | 142,731.00 |
| Jun 30, 2021 | 39,000.00 |
| Mar 31, 2021 | 26,988.00 |
| Dec 31, 2020 | 59,281.00 |
| Sep 30, 2020 | 8,633.00 |
| Jun 30, 2020 | 4,817.00 |
| Dec 31, 2019 | 9,214.00 |
| Sep 30, 2019 | 6,116.00 |